CD14 and skin basal cell carcinoma: Skin-resident macrophages (CD14+HLA-DR+) were greater in BCC (42.54% ± 8.83% [n = 6]) than normal skin (20.94% ± 2.10% [P < 0.05, n = 5]), but were also evident within SCC (37.75% ± 4.50% [n = 13]).